The Goldman Sachs Group began coverage on shares of Dynavax Technologies (NASDAQ:DVAX – Free Report) in a report published on Thursday morning, Marketbeat reports. The firm issued a neutral rating and a $20.00 price objective on the biopharmaceutical company’s stock. A number of other analysts also recently commented on DVAX. JMP Securities upped their target […]
Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) CMO Robert Janssen sold 1,500 shares of the stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $15.00, for a total value of $22,500.00. Following the completion of the transaction, the chief marketing officer now directly owns […]
Five people around Watford in New Year Honours list watfordobserver.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from watfordobserver.co.uk Daily Mail and Mail on Sunday newspapers.
Oligonucleotide API Market 2022 Key Players, SWOT Analysis, Key Indicators and Forecast to 2030 eturbonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eturbonews.com Daily Mail and Mail on Sunday newspapers.
Mizuho Markets Americas LLC reduced its stake in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 9.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 682,707 shares of the biopharmaceutical company’s stock after selling 74,200 shares during the period. Dynavax […]